SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2.

Despite mounting evidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) engagement with immune cells, most express little, if any, of the canonical receptor of SARS-CoV-2, angiotensin-converting enzyme 2 (ACE2). Here, using a myeloid cell receptor-focused ectopic expression screen, we identified several C-type lectins (DC-SIGN, L-SIGN, LSECtin, ASGR1, and CLEC10A) ...
and Tweety family member 2 (TTYH2) as glycan-dependent binding partners of the SARS-CoV-2 spike. Except for TTYH2, these molecules primarily interacted with spike via regions outside of the receptor-binding domain. Single-cell RNA sequencing analysis of pulmonary cells from individuals with coronavirus disease 2019 (COVID-19) indicated predominant expression of these molecules on myeloid cells. Although these receptors do not support active replication of SARS-CoV-2, their engagement with the virus induced robust proinflammatory responses in myeloid cells that correlated with COVID-19 severity. We also generated a bispecific anti-spike nanobody that not only blocked ACE2-mediated infection but also the myeloid receptor-mediated proinflammatory responses. Our findings suggest that SARS-CoV-2-myeloid receptor interactions promote immune hyperactivation, which represents potential targets for COVID-19 therapy.
Mesh Terms:
Angiotensin-Converting Enzyme 2, Binding Sites, COVID-19, Cell Line, Cytokines, Gene Expression Regulation, Host-Pathogen Interactions, Humans, Inflammation Mediators, Lectins, C-Type, Membrane Proteins, Models, Molecular, Myeloid Cells, Neoplasm Proteins, Protein Binding, Protein Conformation, SARS-CoV-2, Single-Domain Antibodies, Spike Glycoprotein, Coronavirus, Structure-Activity Relationship
Immunity
Date: Dec. 08, 2020
Download Curated Data For This Publication
233406
Switch View:
  • Interactions 7